Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 January 2007. doi:10.1136/bjo.2006.111872
British Journal of Ophthalmology 2007;91:1593-1595
Copyright © 2007 by the BMJ Publishing Group Ltd.

SCIENTIFIC REPORT

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema

L L Knudsen1, H-H Lervang2, S Lundbye-Christensen3 and A Gorst-Rasmussen3

1 Department of Ophthalmology, Aarhus University Hospital, Aalborg Sygehus Syd, Aalborg, Denmark
2 Department of Medical Endocrinology, Aarhus University Hospital, Aalborg Sygehus Syd, Aalborg, Denmark
3 Department of Mathematical Sciences, Aalborg University, Aalborg Øst, Denmark

Correspondence to:
L L Knudsen, Department of Ophthalmology, Aarhus University Hospital, Aalborg Sygehus Syd, Hobrovej 18–22, DK-9100 Aalborg, Denmark; u19204{at}aas.nja.dk

ABSTRACT

Background: The influence of non-ophthalmic parameters on the prevalence of clinically significant macular oedema has not been unambiguously established. The present study was initiated with the aim of clarification.

Methods: This cross-sectional study comprised 656 type 1 and 328 type 2 diabetic subjects undergoing retinopathy screening in the county of North Jutland. The association between the presence of clinically significant macular oedema and blood pressure, HbA1c, BMI, age, onset of diabetes, duration of diabetes, blood-pressure-reducing medication, lipid-lowering medication, neuropathy and urinary albumin excretion was explored using multiple logistic regression analysis.

Results: We found no significant association between the presence of clinically significant macular oedema and any of the examined parameters in type 1 diabetic subjects. In type 2 diabetic subjects, the duration of diabetes, HbA1c, neuropathy and increased urinary albumin excretion was significantly associated with the presence of clinically significant macular oedema.

Conclusions: The risk factors for clinically significant macular oedema differ in type 1 and type 2 diabetic subjects and can account only in part for this manifestation.

Abbreviations: CSMO, clinically significant macular oedema

FOOTNOTES

Competing interests: None declared.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Ophthalmology Jobs

Ophthalmology Jobs